Autopsy report · NCT00604552

AneuRx Post Market Study in the Treatment of AAA

“Mutual agreement between FDA closed the 522 postmarket surveillance Registry.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 years 5 months after it had already started.
• Ran for about 5 years 7 months before it stopped.
• 349 participants enrolled.
• Results were posted on the registry 4 years 5 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Medtronic Cardiovascular

Sponsor type

Industry

Conditions

Abdominal Aneurysm

Interventions

AneuRx Stent Graft

Participants

349

Sites

8

Countries

United States

Trials that died the same way

• A Postmarket Surveillance Study of the Paradigm Spine Dynamic Stabilization System (DSS)
  “FDA reclassified so all 522 studies were stopped,” (60% match in meaning)
• Fampridine Pregnancy Exposure Registry
  “Due to low enrollment, registration closed in agreement with the Regulatory Agency” (58% match in meaning)
• Parkinson's Disease Genetics Database
  “Enrollment into this registry was not as robust as investigator envisioned. Thus, the registry was closed.” (58% match in meaning)
• Subcutaneous Recombinant Human Hyaluronidase: Workflow Analysis and Emergency Department Design
  “This study was closed before accrual due to FDA recall of Medication” (56% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.